PHASE II STUDY OF BEVACIZUMAB PLUS ETOPOSIDE AMONG RECURRENT MALIGNANT GLIOMA PATIENTS: FINAL STUDY RESULTS
Publication
, Conference
Reardon, DA; Desjardins, A; Vredenburgh, JJ; Gururangan, S; Peters, KB; Norfleet, JA; Friedman, AH; Friedman, HS
Published in: NEURO-ONCOLOGY
December 1, 2009
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
December 1, 2009
Volume
11
Issue
6
Start / End Page
905 / 905
Location
Yokohama, JAPAN
Publisher
OXFORD UNIV PRESS INC
Conference Name
3rd Quadrennial Meeting of the World-Federation-of-Neuro-Oncoloyg/6th Meeting of the Asian-Society-for-Neuro-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Reardon, D. A., Desjardins, A., Vredenburgh, J. J., Gururangan, S., Peters, K. B., Norfleet, J. A., … Friedman, H. S. (2009). PHASE II STUDY OF BEVACIZUMAB PLUS ETOPOSIDE AMONG RECURRENT MALIGNANT GLIOMA PATIENTS: FINAL STUDY RESULTS. In NEURO-ONCOLOGY (Vol. 11, pp. 905–905). Yokohama, JAPAN: OXFORD UNIV PRESS INC.
Reardon, David A., Annick Desjardins, James J. Vredenburgh, Sridharan Gururangan, Katherine B. Peters, Julie A. Norfleet, Allan H. Friedman, and Henry S. Friedman. “PHASE II STUDY OF BEVACIZUMAB PLUS ETOPOSIDE AMONG RECURRENT MALIGNANT GLIOMA PATIENTS: FINAL STUDY RESULTS.” In NEURO-ONCOLOGY, 11:905–905. OXFORD UNIV PRESS INC, 2009.
Reardon DA, Desjardins A, Vredenburgh JJ, Gururangan S, Peters KB, Norfleet JA, et al. PHASE II STUDY OF BEVACIZUMAB PLUS ETOPOSIDE AMONG RECURRENT MALIGNANT GLIOMA PATIENTS: FINAL STUDY RESULTS. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2009. p. 905–905.
Reardon, David A., et al. “PHASE II STUDY OF BEVACIZUMAB PLUS ETOPOSIDE AMONG RECURRENT MALIGNANT GLIOMA PATIENTS: FINAL STUDY RESULTS.” NEURO-ONCOLOGY, vol. 11, no. 6, OXFORD UNIV PRESS INC, 2009, pp. 905–905.
Reardon DA, Desjardins A, Vredenburgh JJ, Gururangan S, Peters KB, Norfleet JA, Friedman AH, Friedman HS. PHASE II STUDY OF BEVACIZUMAB PLUS ETOPOSIDE AMONG RECURRENT MALIGNANT GLIOMA PATIENTS: FINAL STUDY RESULTS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2009. p. 905–905.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
December 1, 2009
Volume
11
Issue
6
Start / End Page
905 / 905
Location
Yokohama, JAPAN
Publisher
OXFORD UNIV PRESS INC
Conference Name
3rd Quadrennial Meeting of the World-Federation-of-Neuro-Oncoloyg/6th Meeting of the Asian-Society-for-Neuro-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences